FIA
GSK icon

Foundations Investment Advisors’s GSK GSK Stock Holding History

Foundations Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$737K Buy
14,053
+2,393
+21% +$127K 0.01% 654
2026
Q1 		$644K Buy
11,660
+1,410
+14% +$76.4K 0.01% 639
2025
Q4 		$503K Buy
10,250
+225
+2% +$10.5K 0.01% 712
2025
Q3 		$433K Sell
10,025
-1,639
-14% -$64K 0.01% 709
2025
Q2 		$448K Buy
11,664
+1,014
+10% +$38.7K 0.01% 621
2025
Q1 		$413K Sell
10,650
-1,067
-9% -$39.1K 0.01% 625
2024
Q4 		$396K Buy
11,717
+1,595
+16% +$57.4K 0.01% 594
2024
Q3 		$414K Buy
10,122
+466
+5% +$19.1K 0.01% 558
2024
Q2 		$372K Buy
9,656
+1,132
+13% +$47.6K 0.01% 561
2024
Q1 		$365K Sell
8,524
-1,153
-12% -$47.5K 0.01% 533
2023
Q4 		$393K Sell
9,677
-1,423
-13% -$51.1K 0.01% 485
2023
Q3 		$402K Buy
+11,100
New +$394K 0.01% 444
2023
Q1 		– Sell
-62,382
Closed -$2.19M – 525
2022
Q4 		$2.19M Buy
62,382
+50,800
+439% +$1.69M 0.09% 122
2022
Q3 		$341K Buy
+11,582
New +$439K 0.01% 306

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Foundations Investment Advisors's GSK Position: Q2 2026 in Review

Foundations Investment Advisors increased its GSK (GSK) stake by 21% in Q2 2026, buying an estimated $127K and bringing the position to 14,053 shares worth $737K. The position accounts for 0.01% of the portfolio, ranked #654.

Foundations Investment Advisors first reported a position in GSK in Q3 2022 and has held it in 14 quarters since. The position peaked at $2.19M in Q4 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Foundations Investment Advisors held 14,053 shares of GSK worth $737K as of Q2 2026.
  • Foundations Investment Advisors bought 2,393 GSK shares in Q2 2026, an estimated $127K.
  • GSK made up 0.01% of Foundations Investment Advisors's portfolio in Q2 2026, its #654 holding.
  • Foundations Investment Advisors first reported a position in GSK in Q3 2022 and has held it in 14 quarters since.
  • Foundations Investment Advisors's GSK position peaked at $2.19M in Q4 2022.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.